The SARS-CoV-2 Omicron variant escapes neutralization by antibodies targeting the pan-coronavirus epitope in a spike fusion intermediate via steric hindrance, but reducing the antibody size overcomes this barrier and expands its range of accessible targets.
- Zhiheng Bao
- Zhimin Liu
- Xiaoyu Sun